Malignancy in Membranous Nephropathy: Evaluation of Incidence

Table 1

Cohort characteristics at time of MN diagnosis.

Age (years)	56 (41–65)
Male	117 (58.2%)
Follow-up (months)	88 (45–117)
Serum albumin g/L	29 (23–35)
Proteinuria g/d	5 (2.6–9.55)
eGFR ml/min	70 (43.2–97.5)
Haematuria	84, no haematuria (43.3%)
	51, microscopic haematuria (26.3%)
	59, gross haematuria (30.4%)

Results are expressed as median (interquartile range) or as percentage.